Lv41
730 积分 2022-12-04 加入
Efficacy, Safety, Blood Kinetics, and213Bi Distribution Studies of [225Ac]Ac-SibuDAB in Prostate Cancer Patients
1小时前
已完结
Designing nanozymes for in vivo applications
3个月前
已完结
Dual-targeted alpha therapy mitigates prostate cancer and boosts immune checkpoint blockade therapy
3个月前
已完结
An Anti-EGFR Antibody-Drug Radioconjugate Labeled with Actinium-225 Elicits Durable Anti-Tumor Responses in KRAS and BRAF Mutant Colorectal Cancer
4个月前
已完结
Efficacy, Safety, Blood Kinetics, and213Bi Distribution Studies of [225Ac]Ac-SibuDAB in Prostate Cancer Patients
4个月前
已完结
The Future of Follicular Lymphoma Management: Strategies on the Horizon
5个月前
已完结
Building the Future Management of Follicular Lymphoma with T-Cell-Redirecting Strategies
5个月前
已完结
Tumor Targeting of 211At-Labeled Antibody under Sodium Ascorbate Protection against Radiolysis
5个月前
已完结
Enhancing the therapeutic index of [211At]YF2 with iodo pseudo carrier: A simple strategy for reducing accumulation in kidneys, salivary and lacrimal glands
5个月前
已关闭
Controlling Multivalent Binding through Surface Chemistry: Model Study on Streptavidin
5个月前
已完结
皖公网安备34019202002308
